STOPBANG As A Screening Tool for Obstructive Sleep Apnoea in Pregnancy

Launched by CITY HOSPITALS SUNDERLAND NHS FOUNDATION TRUST · Sep 3, 2015

Keywords

ClinConnect Summary

Obstructive sleep apnoea (OSA) is a condition in which the muscles and soft tissues of the throat collapse during sleep, resulting in them stopping breathing for a short period. It affects around 4% of all pregnant women and is more common in obese people. Pregnant women with untreated OSA are more likely to have pregnancy complications and are more likely to need a caesarean section. Babies born to mothers with untreated OSA are more likely to need neonatal treatment. If OSA is diagnosed and treated then these risks are reduced. In non-pregnant patients presenting for surgery, an screening...

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Pregnant women
• • Body mass index ≥ 40 at first midwife appointment
• • Women ≥ 18 years of age
• Exclusion Criteria:
• • Pre-existing obstructive sleep apnoea on treatment
• • Pre-existing restrictive or obstructive respiratory disease
• • Women with another cause of sleep apnoea (e.g. central sleep apnoea)
• • Women under 18 years of age
• • Women who do not provide or refuse consent
• • Women lacking capacity to consent